These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29337488)

  • 1. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
    Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
    J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
    Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
    Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
    Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
    Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro.
    Yan L; Gao S; Shui S; Liu S; Qu H; Liu C; Zheng L
    Int J Biol Macromol; 2020 Nov; 162():1303-1310. PubMed ID: 32603733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA
    Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
    Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA.
    Liang J; Zhang X; He S; Miao Y; Wu N; Li J; Gan Y
    J Control Release; 2018 Sep; 286():348-357. PubMed ID: 30077738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.
    Ashrafizadeh M; Delfi M; Hashemi F; Zabolian A; Saleki H; Bagherian M; Azami N; Farahani MV; Sharifzadeh SO; Hamzehlou S; Hushmandi K; Makvandi P; Zarrabi A; Hamblin MR; Varma RS
    Carbohydr Polym; 2021 May; 260():117809. PubMed ID: 33712155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides.
    Du Z; Liu J; Zhang T; Yu Y; Zhang Y; Zhai J; Huang H; Wei S; Ding L; Liu B
    Food Chem; 2019 Jul; 286():530-536. PubMed ID: 30827643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.
    Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D
    J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios.
    Hejjaji EMA; Smith AM; Morris GA
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1610-1617. PubMed ID: 30282010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral siRNA Delivery to Treat Colorectal Liver Metastases.
    Kang SH; Revuri V; Lee SJ; Cho S; Park IK; Cho KJ; Bae WK; Lee YK
    ACS Nano; 2017 Oct; 11(10):10417-10429. PubMed ID: 28902489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.